Cytokinetics, Incorporated (CYTK)
Market Closed
17 Jul, 20:00
$
80. 18
-0.18
-0.224%
$
10.56B Market Cap
- P/E Ratio
- Div Yield
1.59M Volume
-4.45 Eps
$ 80.36
Previous Close 
Want to track CYTK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cytokinetics, Incorporated (CYTK) Statistics
Valuation metrics
Market Cap 10.56B
Enterprise value 11.14B
Trailing P/E (ttm) -11.74
Forward P/E -
PEG ratio 0.44
Price/Sales (ttm) 94.29
Price/Book (mrq) -11.96
Enterprise Value/Revenue 105.24
Enterprise Value/EBITDA -15.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.82M
Average volume (90 days) 2.81M
Price summary
52-Week low 32.89
52-Week high 88.31
Beta -
50-Day moving average 79.48
200-Day moving average 67.74
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 25 Jun 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -7.84%
Operating margin -6.05%
Operational effectiveness
Return on assets -0.65%
Return on equity 1.4%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.86
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.73
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.64
Total debt (mrq) -
Total Debt/Equity (mrq) -1.56
Current ratio (mrq) 4.21%
Book value per share (mrq) -6.71
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
